Concordia Healthcare (CXRX) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Concordia Healthcare Announces Third Quarter 2015 Results
November 12, 2015 5:00 PM EST- A transformational quarter with strong performance by legacy business -
Third Quarter 2015 Highlights
Concordia announced its acquisition of Amdipharm Mercury Limited ("AMCo") for $3.3 billion1. Adjusted EBITDA2 of $71.7 million, growing 254 per cent versus the same period in 2014. Adjusted EPS2 of $1.46, growing 157 per cent over the third quarter in 2014. Revenue growth of 161 per cent to $94.9 million compared to the third quarter of 2014.2015 Nine Month Highlights
Revenue growth of 163 per cent to $208.9 million compared to the same period in 2014.... More